Literature DB >> 17070947

Biotechnology in South Africa.

Thomas E Cloete1, Louis H Nel, Jacques Theron.   

Abstract

Since adopting the National Biotechnology Strategy in 2001, the South African government has established several regional innovation centres and has put in place initiatives to encourage international partnerships that can spur internal development of life science ventures. This strategy seeks to capitalize on the high quality of research carried out in public research institutions and universities but is hampered, somewhat, by the lack of entrepreneurial culture among South African researchers due to, among other reasons, the expenses involved in registering foreign patents. Although private sector development is still relatively embryonic, start-ups are spinning out of universities and pre-existing companies. These represent a vital source of innovations for commercialization in the future, provided that the challenges facing the emerging South African biotechnology industry can be overcome.

Mesh:

Year:  2006        PMID: 17070947     DOI: 10.1016/j.tibtech.2006.10.009

Source DB:  PubMed          Journal:  Trends Biotechnol        ISSN: 0167-7799            Impact factor:   19.536


  2 in total

1.  Small but tenacious: South Africa's health biotech sector.

Authors:  Sara Al-Bader; Sarah E Frew; Insiya Essajee; Victor Y Liu; Abdallah S Daar; Peter A Singer
Journal:  Nat Biotechnol       Date:  2009-05       Impact factor: 54.908

2.  In vitro production of alkaloids: Factors, approaches, challenges and prospects.

Authors:  Sayeed Ahmad; Madhukar Garg; Ennus Tajuddin Tamboli; M Z Abdin; S H Ansari
Journal:  Pharmacogn Rev       Date:  2013-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.